- Home
- CPRX vs BATRA Comparison
CPRX vs BATRA Comparison
Compare CPRX & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- BATRA
- Stock Information
- Founded
- CPRX 2002
- BATRA 1991
- Country
- CPRX United States
- BATRA United States
- Employees
- CPRX N/A
- BATRA N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- BATRA Broadcasting
- Sector
- CPRX Health Care
- BATRA Industrials
- Exchange
- CPRX Nasdaq
- BATRA Nasdaq
- Market Cap
- CPRX 2.5B
- BATRA 2.6B
- IPO Year
- CPRX 2006
- BATRA N/A
- Fundamental
- Price
- CPRX $22.34
- BATRA $41.46
- Analyst Decision
- CPRX Strong Buy
- BATRA Strong Buy
- Analyst Count
- CPRX 7
- BATRA 2
- Target Price
- CPRX $31.14
- BATRA $53.50
- AVG Volume (30 Days)
- CPRX 820.3K
- BATRA 37.2K
- Earning Date
- CPRX 11-06-2024
- BATRA 11-06-2024
- Dividend Yield
- CPRX N/A
- BATRA N/A
- EPS Growth
- CPRX 114.68
- BATRA N/A
- EPS
- CPRX 1.18
- BATRA N/A
- Revenue
- CPRX $460,482,000.00
- BATRA $678,378,000.00
- Revenue This Year
- CPRX $23.98
- BATRA $10.38
- Revenue Next Year
- CPRX $18.27
- BATRA $5.23
- P/E Ratio
- CPRX $18.72
- BATRA N/A
- Revenue Growth
- CPRX 32.17
- BATRA 5.31
- 52 Week Low
- CPRX $13.12
- BATRA $39.67
- 52 Week High
- CPRX $24.27
- BATRA $46.65
- Technical
- Relative Strength Index (RSI)
- CPRX 54.94
- BATRA 44.27
- Support Level
- CPRX $20.93
- BATRA $40.92
- Resistance Level
- CPRX $22.49
- BATRA $41.84
- Average True Range (ATR)
- CPRX 0.60
- BATRA 0.66
- MACD
- CPRX 0.00
- BATRA -0.03
- Stochastic Oscillator
- CPRX 77.06
- BATRA 27.12
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.